Problems faced by scleroderma (SSc) patients: The scleroderma concerns questionnaire.

被引：0
|
作者：
Arsenault, Thomas
Khanna, Dinesh
Hansdottir, Ingunn
Ahmed, Mansoor
Furst, Daniel E.
Ginsburg, Shaari
Weisman, Michael H.
Clements, Philip J.
Malcarne, Vanessa L.
机构：
[1] San Diego State Univ, San Diego, CA 92182 USA
[2] Univ Cincinnati, Cincinnati, OH USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S484 / S484
页数：1
相关论文
共 50 条
  • [31] Intensive immunosuppression and stem cell transplantation (SCT) in scleroderma (SSC).
    Furst, DE
    McSweeney, P
    Nelson, JL
    Nash, R
    Wener, M
    Sullivan, KM
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S102 - S102
  • [32] ROLE OF TGF-BETA IN THE ACQUISITION OF THE SCLERODERMA (SSC) PHENOTYPE
    MCWHIRTER, A
    COLOSETTI, P
    RUBIN, K
    BLACK, CM
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S182 - S182
  • [33] Efficacy and safety of etanercept in scleroderma (SSc) joint disease.
    Lam, GK
    Woods, A
    Hummers, LK
    Wigley, FM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S588 - S589
  • [34] HOW TO DIFFERENTIATE SSC FROM SCLERODERMA-LIKE DISORDER?
    Tyndall, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S8 - S8
  • [35] Best Practices in Scleroderma: An Analysis of Guidelines for Management in SSc from a Large Database (CSRG: Canadian Scleroderma Research Group)
    Harding, Sarah
    Khimdas, Sarit
    Bonner, Ash
    Baron, Murray
    Pope, Janet
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1306 - 1306
  • [36] SCLERODERMA-INDUCING GLYCOSAMINOGLYCAN IN URINE OF PATIENTS WITH SYSTEMIC SCLERODERMA
    ISHIKAWA, H
    SAITO, Y
    YAMAKAGE, A
    KITABATAKE, M
    DERMATOLOGICA, 1978, 156 (04): : 193 - 204
  • [37] DIFFERENTIAL EXPRESSION OF CHI3L1 IDENTIFIES SUBGROUPS OF SCLERODERMA (SSC) PATIENTS
    Ho, Y.
    Baron, M.
    Roughley, P.
    Mort, J.
    Recklies, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S104 - S105
  • [38] Tomographic Pattern In Patients With Scleroderma Sine Scleroderma Compared To Patients With Systemic Sclerosis
    Mateos, H.
    Rojas-Serrano, J.
    Mayorga, J.
    Buendia-Roldan, I.
    Estrada, A.
    Mejia, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [39] DISEASE PROGRESSION IN 282 PATIENTS WITH UNDIFFERENTIATED SSC - DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLERODERMA
    Moinzadeh, P.
    Blank, N.
    Siegert, E.
    Henes, J.
    Susok, L.
    Distler, J. H. W.
    Juche, A.
    Worm, M.
    Gil, H. C.
    Schmeiser, T.
    Zeidler, G.
    Gaebelein-Wissing, N.
    Krieg, T.
    Sunderkoetter, C.
    Kreuter, A.
    Sardy, M.
    Riemekasten, G.
    Mueller-Ladner, U.
    Frerix, M.
    Kuhr, K.
    Hunzelmann, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 952 - 952
  • [40] Identification of an expression-based set of genes to predict the subset of patients with systemic scleroderma (SSc)
    Moinzadeh, P.
    Frommolt, P.
    Franitza, M.
    Toliat, M. R.
    Becker, K.
    Nuernberg, P.
    Nihtyanova, S. I.
    Ahrazoglu, M.
    Belz, D.
    Hunzelmann, N.
    Abraham, D.
    Ong, V. H.
    Mouthon, L.
    Hesselstrand, R.
    Denton, C. P.
    Krieg, T.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 10 - 10
12345